BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31956077)

  • 1. Upstaging to pT3a disease in patients undergoing robotic partial nephrectomy for cT1 kidney cancer: Outcomes and predictors from a multi-institutional dataset.
    Veccia A; Antonelli A; Minervini A; Mottrie A; Dell'Oglio P; Ashrafi AN; Larcher A; Eun D; Bradshaw A; Amparore D; Brassetti A; Hampton LJ; Simeone C; Mari A; Carini M; De Naeyer G; Yang K; Capitanio U; Simone G; Porpiglia F; Derweesh I; Aron M; Autorino R
    Urol Oncol; 2020 Apr; 38(4):286-292. PubMed ID: 31956077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative morbidity, oncological outcomes and predictors of pT3a upstaging for patients undergoing partial nephrectomy for cT1 tumors.
    Mouracade P; Kara O; Dagenais J; Maurice MJ; Nelson RJ; Malkoc E; Kaouk JH
    World J Urol; 2017 Sep; 35(9):1425-1433. PubMed ID: 28197727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upstaging to pT3a in Patients Undergoing Partial or Radical Nephrectomy for cT1 Renal Tumors: A Systematic Review and Meta-analysis of Outcomes and Predictive Factors.
    Veccia A; Falagario U; Martini A; Marchioni M; Antonelli A; Simeone C; Cormio L; Capitanio U; Mir MC; Derweesh I; Van Poppel H; Porpiglia F; Autorino R
    Eur Urol Focus; 2021 May; 7(3):574-581. PubMed ID: 32571744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes and predictors of clinical T1 renal mass (cT1) upstaged to pathological T3a (pT3a) after partial nephrectomy: A single-center experience.
    Pathak N; Ganpule A; Patel D; Singh A; Shete N; Sabnis R; Desai M
    Int J Urol; 2024 Mar; 31(3):252-257. PubMed ID: 38124339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncological outcomes and pathological characteristics of cT1 upstaging to pT3a renal cell carcinoma compared with de novo pT3a tumors.
    Senguttuvan Karthikeyan V; Mallya A; Sivaraman A; Galiano M; Rozet F; Cathala N; Barret E; Mombet A; Prapotnich D; Sanchez-Salas R; Cathelineau X
    Actas Urol Esp (Engl Ed); 2019 Jun; 43(5):234-240. PubMed ID: 30857765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robotic surgery does not affect upstaging of T1 renal masses.
    Davaro F; Roberts J; May A; McFerrin C; Siddiqui S; Hamilton Z
    J Robot Surg; 2020 Jun; 14(3):447-454. PubMed ID: 31456083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional Analysis.
    Patel SH; Uzzo RG; Larcher A; Peyronnet B; Lane BR; Pruthi D; Reddy M; Capitanio U; Joshi S; Noyes S; Eldefrawy A; Ghali F; Meagher MF; Hamilton ZA; Yim K; Nasseri R; Bradshaw AW; Dey S; Kirmiz S; Wan F; Liss MA; Bensalah K; Montorsi F; Derweesh IH
    Clin Genitourin Cancer; 2020 Dec; 18(6):e723-e729. PubMed ID: 32600941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic features of upstaged pT3a renal tumors with fat invasion after robot-assisted partial nephrectomy: is it time for a new subclassification?
    Di Maida F; Campi R; Grosso AA; Lambertini L; Cadenar A; Giudici S; Pecoraro A; Mari A; Serni S; Minervini A;
    Eur J Surg Oncol; 2023 Apr; 49(4):862-867. PubMed ID: 36528511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and prognostic implications for pathologic upstaging to T3a after partial nephrectomy.
    Beksac AT; Paulucci DJ; Gul Z; Reddy BN; Kannappan M; Martini A; Sfakianos JP; Gin GE; Abaza R; Eun DD; Bhandari A; Hemal AK; Porter J; Badani KK
    Minerva Urol Nefrol; 2019 Aug; 71(4):395-405. PubMed ID: 30230296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.
    Gorin MA; Ball MW; Pierorazio PM; Tanagho YS; Bhayani SB; Kaouk JH; Rogers CG; Stifelman MD; Khalifeh A; Kumar R; Sivarajan G; Allaf ME
    J Urol; 2013 Nov; 190(5):1907-11. PubMed ID: 23764083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma: Outcomes According to Surgical Technique and Predictors of Upstaging.
    Jeong SH; Kim JK; Park J; Jeon HJ; Yoon MY; Jeong CW; Ku JH; Kim HH; Kwak C
    PLoS One; 2016; 11(11):e0166183. PubMed ID: 27861519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robotic partial nephrectomy vs minimally invasive radical nephrectomy for clinical T2a renal mass: a propensity score-matched comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group.
    Bradshaw AW; Autorino R; Simone G; Yang B; Uzzo RG; Porpiglia F; Capitanio U; Porter J; Bertolo R; Minervini A; Lau C; Jacobsohn K; Ashrafi A; Eun D; Mottrie A; White WM; Schips L; Challacombe BJ; De Cobelli O; Mir CM; Veccia A; Larcher A; Kutikov A; Aron M; Dasgupta P; Montorsi F; Gill IS; Sundaram CP; Kaouk J; Derweesh IH
    BJU Int; 2020 Jul; 126(1):114-123. PubMed ID: 32232920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of Pathologic T3a Upstaging in Clinical T1 Renal Masses Undergoing Nephrectomy.
    Ramaswamy K; Kheterpal E; Pham H; Mohan S; Stifelman M; Taneja S; Huang WC
    Clin Genitourin Cancer; 2015 Aug; 13(4):344-349. PubMed ID: 25680295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging Criteria.
    Hamilton ZA; Capitanio U; Pruthi D; Ghali F; Larcher A; Patel DN; Eldefrawy A; Patel S; Cotta BH; Bradshaw AW; Meagher MF; Miller NS; Carenzi C; Wan F; Liss MA; McGregor T; Montorsi F; Derweesh IH
    Urology; 2020 Apr; 138():60-68. PubMed ID: 31836465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological Upstaging of Clinical T1 to Pathological T3a Renal Cell Carcinoma: A Multi-institutional Analysis of Short-term Outcomes.
    Nayak JG; Patel P; Saarela O; Liu Z; Kapoor A; Finelli A; Tanguay S; Rendon R; Moore R; Black PC; Lacombe L; Breau RH; Kawakami J; Drachenberg DE
    Urology; 2016 Aug; 94():154-60. PubMed ID: 27041471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and internal validation of a nomogram predicting 3-year chronic kidney disease upstaging following robot-assisted partial nephrectomy.
    Flammia RS; Anceschi U; Tuderti G; Di Maida F; Grosso AA; Lambertini L; Mari A; Mastroianni R; Bove A; Capitanio U; Amparore D; Lee J; Pandolfo SD; Fiori C; Minervini A; Porpiglia F; Eun D; Autorino R; Leonardo C; Simone G
    Int Urol Nephrol; 2024 Mar; 56(3):913-921. PubMed ID: 37848745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?
    Capitanio U; Stewart GD; Klatte T; Akdogan B; Roscigno M; Marszalek M; Dell'Oglio P; Zaffuto E; Rodriguez Faba O; Salagierski M; Lingard J; Carini M; Ouzaid I; Mir MC; Montorsi F; Da Pozzo LF; Stief C; Minervini A; Brookman-May SD
    Eur Urol Focus; 2018 Dec; 4(6):972-977. PubMed ID: 28753867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Multi-Institutional Analysis of the Effect of Positive Surgical Margins Following Robot-Assisted Partial Nephrectomy on Oncologic Outcomes.
    Rothberg MB; Paulucci DJ; Okhawere KE; Reynolds CR; Badani KK; Abaza R; Eun D; Bhandari A; Porter J; Hemal AK
    J Endourol; 2020 Mar; 34(3):304-311. PubMed ID: 31931607
    [No Abstract]   [Full Text] [Related]  

  • 19. The preoperative predictive factors for pathological T3a upstaging and positive surgical margin of clinical T1 renal cell carcinoma.
    Çil G; Yilmaz M; Sahin Y; Ulus I; Canıtez IO; Kandıralı IE
    Actas Urol Esp (Engl Ed); 2024 May; 48(4):311-318. PubMed ID: 38369290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Robot-assisted Partial Nephrectomy for Clinical T2 Renal Tumors: A Multicenter Analysis (ROSULA Collaborative Group).
    Bertolo R; Autorino R; Simone G; Derweesh I; Garisto JD; Minervini A; Eun D; Perdona S; Porter J; Rha KH; Mottrie A; White WM; Schips L; Yang B; Jacobsohn K; Uzzo RG; Challacombe B; Ferro M; Sulek J; Capitanio U; Anele UA; Tuderti G; Costantini M; Ryan S; Bindayi A; Mari A; Carini M; Keehn A; Quarto G; Liao M; Chang K; Larcher A; De Naeyer G; De Cobelli O; Berardinelli F; Zhang C; Langenstroer P; Kutikov A; Chen D; De Luyk N; Sundaram CP; Montorsi F; Stein RJ; Haber GP; Hampton LJ; Dasgupta P; Gallucci M; Kaouk J; Porpiglia F
    Eur Urol; 2018 Aug; 74(2):226-232. PubMed ID: 29784191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.